These are pro-forma results, namely those adjusted to reflect the results of acquired companies given that MedLife is one of the most dynamic players in terms of purchases. By comparison, 1Q/2021 pro-forma net profit stood at RON37 million and turnover at around RON373 million.
Not including the pro-forma results, MedLife in 1Q/2021 posted net consolidated profit of RON30 million, down 18%, and RON421 million revenues, up 24%.
According to the company’s representatives, the 1Q figures reflect the fact that the market is back in motion, after two pandemic years.
“The two years of pandemic, but also the war in Ukraine have shown us health cannot be put on hold. On the contrary, they have confirmed to us that irrespective of the context, we are able to adapt and align to market needs, to be a reliable partner both for companies in Romania and for each Romanian seeking our services,” says Mihai Marcu, MedLife chairman and CEO.
(English version by Catalina Apostoiu)